SITIOS WEB DE ESPAñA
CATALOGAR
Información de dominio y sitio web:
amylyx.es
Acerca del sitio:
Nombre de dominio - amylyx.es
Título del sitio - amylyx.es - This website is for sale! - amylyx Resources and Information.
Ir al sitio web - amylyx.es - This website is for sale! - amylyx Resources and Information.
Las palabras principales cuentan en amylyx.es:
amylyx - 6
this - 4
you - 4
sale - 3
the - 3
domain - 3
sedo - 3
website - 2
and - 2
Ver lista completa de palabras
Ubicación GEO del sitio
Ubicación País - Germany
Proveedor - SEDO GmbH
Site Logo
There is no Open Graph data at amylyx.es
Información para el dominio amylyx.es
dirección IP:
servidores de nombres de dominio:
ns2.sedoparking.com ns1.sedoparking.com
Todos los registros:
☆ amylyx.es. 21600 IN NS ns1.sedoparking.com.
☆ amylyx.es. 21600 IN NS ns2.sedoparking.com.
☆ amylyx.es. 3600 IN MX 0 localhost.
☆ amylyx.es. 3600 IN TXT "v=spf1 -all"
☆ amylyx.es. 300 IN A 64.190.63.222
☆ amylyx.es. 21600 IN SOA ns1.sedoparking.com. hostmaster.sedo.de. 2018051601 86400 10800 604800 86400
Brief facts about amylyx:
Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis. AMX0035 was approved for medical use in Canada as Albrioza, in June 2022, and in the United States, as Relyvrio, in September 2022. It was withdrawn in April, 2024.
Companies based in Cambridge, Massachusetts
Biotechnology companies of the United States
© DMS 2011-